Nonacidic Chemotype Possessing N-Acylated Piperidine Moiety as Potent Farnesoid X Receptor (FXR) Antagonists

被引：12

作者：

Teno, Naoki ^{[1
,2
]}

Yamashita, Yukiko ^{[3
]}

Ig, Yusuke ^{[3
]}

Fujimori, Ko ^{[4
]}

Une, Mizuho ^{[1
,3
]}

Nishimaki-Mogami, Tomoko ^{[5
]}

Hiramoto, Takie ^{[1
]}

Gohda, Keigo ^{[6
]}

机构：

[1] Hiroshima Int Univ, Grad Sch Pharmaceut Sci, 5-1-1 Hirokoshingai, Kure, Hiroshima 7370112, Japan

[2] Hiroshima Int Univ, Fac Clin Nutr, 5-1-1 Hirokoshingai, Kure, Hiroshima 7370112, Japan

[3] Hiroshima Int Univ, Fac Pharmaceut Sci, 5-1-1 Hirokoshingai, Kure, Hiroshima 7370112, Japan

[4] Osaka Univ Pharmaceut Sci, Fac Pharmaceut Sci, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan

[5] Natl Inst Hlth Sci, Setagaya Ku, Kamiyoga 1-18-1, Tokyo 1588501, Japan

[6] Kansai CAMM Kansai, Comp Aided Mol Modeling Res Ctr, 3-32-302 Tsuto, Nishinomiya, Hyogo 6638241, Japan

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2018年 / 9卷 / 02期

基金：

日本学术振兴会;

关键词：

FXR antagonists; benzimidazole scaffold; N-acylated piperidine; triglyceride accumulation; ORPHAN NUCLEAR RECEPTOR; BILE-ACID; ADIPOCYTE DIFFERENTIATION; IDENTIFICATION; OPTIMIZATION; DISCOVERY; LIGANDS; HOMEOSTASIS; DERIVATIVES; MODULATORS;

D O I：

10.1021/acsmedchemlett.7b00363

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Famesoid X receptor (FXR) plays a major role in the control of cholesterol metabolism. Antagonizing transcriptional activity of FXR is an effective means to treat the relevant metabolic syndrome. Some of antagonists so far have the charged functions; however, they may negatively affect the pharmacokinetics. We describe herein a structure activity relationship (SAR) exploration of nonacidic FXR antagonist 6 focusing on two regions in the structure and biological evaluation of nonacidic 10 with the characteristic N-acylated piperidine group obtained from SAR studies. As the robust affinity to FXR is feasible with our nonacidic analogue, 10 is among the most promising candidates for in vivo testing.

引用

页码：78 / 83

页数：6

共 35 条

[1] Discovery and optimization of benzimidazole derivatives as a novel chemotype of farnesoid X receptor (FXR) antagonists
Teno, Naoki
Iguchi, Yusuke
Yamashita, Yukiko
Mori, Nobuhiro
Une, Mizuho
Nishimaki-Mogami, Tomoko
Gohda, Keigo
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (06) : 1787 - 1794
[2] Medicinal Chemistry and Pharmacological Effects of Farnesoid X Receptor (FXR) Antagonists
Lamers, Christina
Schubert-Zsilavecz, Manfred
Merk, Daniel
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (19) : 2188 - 2205
[3] Discovery and SAR study of hydroxyacetophenone derivatives as potent, non-steroidal farnesoid X receptor (FXR) antagonists
Liu, Peng
Xu, Xing
Chen, Lili
Ma, Lei
Shen, Xu
Hu, Lihong
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (05) : 1596 - 1607
[4] Synthesis and biological evaluations of chalcones, flavones and chromenes as farnesoid x receptor (FXR) antagonists
Zhang, Guoning
Liu, Shuainan
Tan, Wenjuan
Verma, Ruchi
Chen, Yuan
Sun, Deyang
Huan, Yi
Jiang, Qian
Wang, Xing
Wang, Na
Xu, Yang
Wong, Chiwai
Shen, Zhufang
Deng, Ruitang
Liu, Jinsong
Zhang, Yanqiao
Fang, Weishuo
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 129 : 303 - 309
[5] Synthesis and discovery of andrographolide derivatives as non-steroidal farnesoid X receptor (FXR) antagonists
Liu, Zhuyun
Law, Wai-Kit
Wang, Decai
Nie, Xin
Sheng, Dekuan
Song, Genrui
Guo, Kai
Wei, Ping
Ouyang, Pingkai
Wong, Chi-Wai
Zhou, Guo-Chun
RSC ADVANCES, 2014, 4 (26): : 13533 - 13545
[6] Discovery of novel, highly potent and selective small molecule farnesoid X receptor (FXR) agonists
Richter, Hans G. F.
Benson, Gregory M.
Bleicher, Konrad H.
Blum, Denise
Chaput, Evelyne
Clemann, Nicole
Feng, Song
Gardes, Christophe
Grether, Uwe
Hartman, Peter
Kuhn, Bernd
Martin, Rainer E.
Plancher, Jean-Marc
Rudolph, Markus
Schuler, Franz
Taylor, Sven
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
[7] Discovery and Optimization of 1,3,4-Trisubstituted-pyrazolone Derivatives as Novel, Potent, and Nonsteroidal Farnesoid X Receptor (FXR) Selective Antagonists
Huang, Huang
Yu, Ying
Gao, Zhenting
Zhang, Yong
Li, Chenjing
Xu, Xing
Jin, Hui
Yan, Wenzhong
Ma, Ruoqun
Zhu, Jin
Shen, Xu
Jiang, Hualiang
Chen, Lili
Li, Jian
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (16) : 7037 - 7053
[8] Synthesis and biological evaluation of novel SIPI-7623 derivatives as farnesoid X receptor (FXR) antagonists
Nian, Si-Yun
Wang, Guo-Ping
Jiang, Zheng-Li
Xiao, Ying
Huang, Mo-Han
Zhou, Yi-Huan
Tan, Xiang-Duan
MOLECULAR DIVERSITY, 2019, 23 (01) : 19 - 33
[9] Synthesis and biological evaluation of novel SIPI-7623 derivatives as farnesoid X receptor (FXR) antagonists
Si-Yun Nian
Guo-Ping Wang
Zheng-Li Jiang
Ying Xiao
Mo-Han Huang
Yi-Huan Zhou
Xiang-Duan Tan
Molecular Diversity, 2019, 23 : 19 - 33
[10] Binding mode of 6ECDCA, a potent bile acid agonist of the Farnesoid X Receptor (FXR)
Costantino, G
Macchiarulo, A
Entrena-Guadix, A
Camaioni, E
Pellicciari, R
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (11) : 1865 - 1868

← 1 2 3 4 →